Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | MedComm |
| Online Access: | https://doi.org/10.1002/mco2.70022 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832594243742334976 |
|---|---|
| author | Ram Abou Zaki Assam El‐Osta |
| author_facet | Ram Abou Zaki Assam El‐Osta |
| author_sort | Ram Abou Zaki |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d1d7697127654d62b5f7e86e8a0ef6ac |
| institution | Kabale University |
| issn | 2688-2663 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | MedComm |
| spelling | doaj-art-d1d7697127654d62b5f7e86e8a0ef6ac2025-01-20T01:45:44ZengWileyMedComm2688-26632025-01-0161n/an/a10.1002/mco2.70022Targeting EZH1/2: tackling epigenetic resistance advances cancer therapyRam Abou Zaki0Assam El‐Osta1Epigenetics in Human Health and Disease ProgramBaker Heart and Diabetes Institute Melbourne Victoria AustraliaEpigenetics in Human Health and Disease ProgramBaker Heart and Diabetes Institute Melbourne Victoria Australiahttps://doi.org/10.1002/mco2.70022 |
| spellingShingle | Ram Abou Zaki Assam El‐Osta Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy MedComm |
| title | Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy |
| title_full | Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy |
| title_fullStr | Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy |
| title_full_unstemmed | Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy |
| title_short | Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy |
| title_sort | targeting ezh1 2 tackling epigenetic resistance advances cancer therapy |
| url | https://doi.org/10.1002/mco2.70022 |
| work_keys_str_mv | AT ramabouzaki targetingezh12tacklingepigeneticresistanceadvancescancertherapy AT assamelosta targetingezh12tacklingepigeneticresistanceadvancescancertherapy |